About the Authors

Tudor I. Oprea

Affiliation Department of Internal Medicine, Comprehensive Cancer Center, University of New Mexico School of Medicine, Albuquerque New Mexico, United States of America

Lily Jan

Affiliation Department of Physiology, University of California–San Francisco, San Francisco, California, United States of America

Gary L. Johnson

Affiliation Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

Bryan L. Roth

Affiliation Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America

Avi Ma’ayan

Affiliation Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America

Stephan Schürer

Affiliation Department of Pharmacology, Miller School of Medicine, Center for Computational Science, University of Miami, Miami, Florida, United States of America

Brian K. Shoichet

Affiliation Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, United States of America

Larry A. Sklar

Affiliation Department of Pathology, Comprehensive Cancer Center, University of New Mexico School of Medicine, Albuquerque, New Mexico, United States of America

Michael T. McManus

michael.mcmanus@ucsf.edu

Affiliation Department of Microbiology and Immunology, UCSF Diabetes Center, University of California–San Francisco, San Francisco, California, United States of America

Competing Interests

The authors have declared that no competing interests exist.